EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BTK drives neutrophil activation for sterilizing antifungal immunity

Jigar V Desai, Marissa A Zarakas, Andrew L Wishart, Mark Roschewski, Mariano A Aufiero, Agnes Donkò, Gustaf Wigerblad, Neta Shlezinger, Markus Plate, Matthew R James, Jean K Lim, Gulbu Uzel und 16 weitere

Journal of Clinical Investigation · 17.06.2024 · 134 (12)

DOI: 10.1172/jci176142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.05.2024. Verfasst von Jigar V Desai und 27 weiteren Autor:innen. Beteiligte Einrichtung: Fungal Pathogenesis Section, Laboratory of Clinical Immunology & Microbiology (LCIM), National Institute of Allergy & Infectious Diseases (NIAID), Na…. Hauptthemen laut MEDLINE: Agammaglobulinaemia Tyrosine Kinase, Neutrophils, Aspergillosis, Neutrophil Activation. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Intramural NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We describe a previously unappreciated role for Bruton’s tyrosine kinase (BTK) in fungal immune surveillance against aspergillosis, an unforeseen complication of BTK inhibitors (BTKi) used for treating B cell lymphoid malignancies. We studied BTK-dependent fungal responses in neutrophils from diverse populations, including healthy donors, patients who were treated with BTKi, and X-linked agammaglobulinemia patients. Upon fungal exposure, BTK was activated in human neutrophils in a TLR2-, Dectin-1-, and FcγR-dependent manner, triggering the oxidative burst. BTK inhibition selectively impeded neutrophil-mediated damage to Aspergillus hyphae, primary granule release, and the fungus-induced oxidative burst by abrogating NADPH oxidase subunit p40 phox and GTPase RAC2 activation. Moreover, neutrophil-specific Btk deletion in mice enhanced aspergillosis susceptibility by impairing neutrophil function, not recruitment or lifespan. Conversely, GM-CSF partially mitigated these deficits by enhancing p47 phox activation. Our findings underline the crucial role of BTK signaling in neutrophils for antifungal immunity and provide a rationale for GM-CSF use to offset these deficits in patients who are susceptible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Agammaglobulinaemia Tyrosine KinaseNeutrophilsAspergillosisNeutrophil ActivationHumansAnimalsMiceMice, KnockoutAgammaglobulinemiaNADPH OxidasesGranulocyte-Macrophage Colony-Stimulating FactorMaleGenetic Diseases, X-LinkedToll-Like Receptor 2Respiratory BurstFemaleRAC2 GTP-Binding ProteinLectins, C-TypeDectin-1

Stichwörter der Autor:innen

Fungal infectionsImmunologyInfectious diseaseInnate immunityNeutrophils

Substanzen

Agammaglobulinaemia Tyrosine KinaseNADPH OxidasesGranulocyte-Macrophage Colony-Stimulating FactorToll-Like Receptor 2RAC2 GTP-Binding ProteinLectins, C-TypeDectin-1BTK protein, humanBtk protein, mouseneutrophil cytosolic factor 1

Autor:innen und Institutionen

  • Fungal Pathogenesis Section, Laboratory of Clinical Immunology & Microbiology (LCIM), National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Lymphoid Malignancies Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA.
  • Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Molecular Defenses Section, LCIM, NIAID, NIH, Bethesda, Maryland, USA.
  • Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, Maryland, USA.
  • Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Förderung

  • NIAID NIH HHS
  • Intramural NIH HHS
  • NCI NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Desai, J. V., Zarakas, M. A., Wishart, A. L., Roschewski, M., Aufiero, M. A., Donkò, A., Wigerblad, G., Shlezinger, N., Plate, M., James, M. R., Lim, J. K., Uzel, G., Bergerson, J. R., Fuss, I., Cramer, R. A., Franco, L. M., Clark, E. S., Khan, W. N., Yamanaka, D., …, & Lionakis, M. S. (2024). BTK drives neutrophil activation for sterilizing antifungal immunity. Journal of Clinical Investigation, 134(12). https://doi.org/10.1172/jci176142

Vancouver

Desai JV, Zarakas MA, Wishart AL, Roschewski M, Aufiero MA, Donkò A, et al. BTK drives neutrophil activation for sterilizing antifungal immunity. Journal of Clinical Investigation. 2024;134(12). doi:10.1172/jci176142

BibTeX
@article{Desai2024,
  author = {Desai, Jigar V and Zarakas, Marissa A and Wishart, Andrew L and Roschewski, Mark and Aufiero, Mariano A and Donkò, Agnes and Wigerblad, Gustaf and Shlezinger, Neta and Plate, Markus and James, Matthew R and Lim, Jean K and Uzel, Gulbu and Bergerson, Jenna Re and Fuss, Ivan and Cramer, Robert A and Franco, Luis M and Clark, Emily S and Khan, Wasif N and Yamanaka, Daisuke and Chamilos, Georgios and El-Benna, Jamel and Kaplan, Mariana J and Staudt, Louis M and Leto, Thomas L and Holland, Steven M and Wilson, Wyndham H and Hohl, Tobias M and Lionakis, Michail S},
  title = {BTK drives neutrophil activation for sterilizing antifungal immunity},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {12},
  doi = {10.1172/jci176142}
}
Kostenlos starten →